Ketoconazole increases cocaine and opioid use in methadone maintained patients

Drug and Alcohol Dependence

Volumn 66, Issue 2, 2002, Pages 173-180

  Kosten, Thomas R ^a   Oliveto, Alison ^a   Sevarino, Kevin A ^b   Gonsai, Kishor ^a   Feingold, Alan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cocaine; Ketoconazole; Opioids; Pharmacotherapy; Stress; Treatment

Indexed keywords

COCAINE; DIAMORPHINE; HYDROCORTISONE; KETOCONAZOLE; METHADONE; OPIATE; PLACEBO;

ADULT; ARTICLE; BONE PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG EFFECT; DRUG USE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; MYALGIA; NAUSEA AND VOMITING; OPIATE ADDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ANALYSIS OF VARIANCE; ANTIFUNGAL AGENTS; CHI-SQUARE DISTRIBUTION; COCAINE-RELATED DISORDERS; DOUBLE-BLIND METHOD; HUMANS; KETOCONAZOLE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; PROPORTIONAL HAZARDS MODELS;

PRIMATES; RODENTIA;

EID: 0036532492     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(01)00198-3     Document Type: Article

References (40)

1. Antiglucocorticoid treatment of refractory depression with ketoconazole: A case report
2. Cocaine-reinforced responding in rhesus monkeys: Pharmacological attenuation of the hypothalamic-pituitary-adrenal axis response
3. Application of hierarchical linear models to assessing change
4. Methadone dosage and retention of patients in maintenance treatment
5. The effect of fluconazole on the clinical pharmacokinetics of methadone
6. Some conceptual and statistical issues in analyses of longitudinal psychiatric data
7. A neuroendocrine role in cocaine reinforcement
8. Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of cocaine self-administration in rats
9. Ketoconazole reduces low dose cocaine self-administration in rats
10. A rating scale for depression
11. Heroin use during methadone maintenance treatment: The importance of methadone dose and cocaine use
12. Adrenocorticotropic hormone, adrenocortical steroids and their synthetic analogs, inhibitors of adrenocortical steroid diosynthesis
13. Substance use disorders in patients with posttraumatic stress disorder: A review of the literature
14. Pathophysiology and treatment of cocaine dependence
15. Comparison of clinician ratings to self-reports of withdrawal during clonidine detoxification of opiate addicts
16. A 2.5 year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts
17. A 2.5 year follow-up of cocaine use among treated opioid addicts: Have our treatments helped?
18. Beta endorphin levels during heroin, methadone, buprenorphine and naloxone challenges: Preliminary findings
19. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence
20. Methadone doses and therapeutic compliance during a methadone maintenance program
21. The fifth edition of the addiction severity index
22. Cocaine effects on pulsatile secretion of anterior pituitary, gonadal, and adrenal hormones
23. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men
24. Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone
25. Response to steroid suppression in major depression resistant to antidepressant therapy
26. Corticosterone levels determine individual vulnerability to amphetamine self-administration
27. Inhibition of corticosterone synthesis by metyrpone decreases cocaine-induced locomotion and relapse of cocaine self-administration
28. Antiglucocorticoids as treatments for depression: Rationale for use and therapeutic potential
29. The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats
30. Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats
31. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats
32. CP154-526, a selective non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug-seeking behavior in cocaine-and heroin-trained rats
33. Buprenorphine vs. methadone maintenance treatment for concurrent opioid dependence and cocaine abuse
34. The use of ketoconazole as an inhibitor of steroid production
35. Pathways to relapse: The neurobiology of drug- and stress-induced relapse to drug-taking
36. Dose-response effects of methadone in the treatment of opioid dependence
37. Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans
38. Ketoconazole administration in hypercortisolemic depression